跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,350 条关于
“EnGeneIC Limited”
全部
11,350
临床试验
1,126
药物
54
机构
1,330
资讯
8,840
4个月前
EnGeneIC Doses First Patient with Novel EGFR-Targeted Nanocell Therapy for Recurrent Glioblastoma
去年
BioCina Partners with EnGeneIC to Manufacture Novel Nanocell Cancer Therapy
去年
EnGeneIC Launches Phase I/IIa Trial of Novel EDV Nanocell Therapy for EGFR-Positive Advanced Cancers
去年
Dupilumab Shows Limited Success in Peanut Allergy Desensitization Study
去年
PharmAust Advances ALS Treatment with New Funding
去年
PARASOL Workshop Suggests Broader Proteinuria Endpoints for FSGS Drug Approval
去年
Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer
去年
Hansoh Pharma's Aumolertinib Plus Chemotherapy Shows Positive Phase III Results in EGFR-Mutated NSCLC
去年
EMA Designates Vivesto's Paccal Vet for Limited Market in Treating Canine Hemangiosarcoma
去年
Evidence Review Finds Limited Effective Treatments for Low Back Pain
第 1 页,共 884 页
上一页
下一页